CINECA IRIS Institutional Research Information System

GAMBALE, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.696
EU - Europa 1.003
AS - Asia 1.000
SA - Sud America 211
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.646
IT - Italia 358
CN - Cina 327
SG - Singapore 307
DE - Germania 219
HK - Hong Kong 192
BR - Brasile 178
AT - Austria 82
SE - Svezia 75
GB - Regno Unito 51
CI - Costa d'Avorio 43
FI - Finlandia 40
BG - Bulgaria 38
FR - Francia 36
VN - Vietnam 30
CA - Canada 29
IN - India 25
TR - Turchia 25
RU - Federazione Russa 24
KR - Corea 22
SN - Senegal 22
JP - Giappone 20
PL - Polonia 16
EE - Estonia 14
MA - Marocco 14
AR - Argentina 13
MX - Messico 11
NL - Olanda 11
BD - Bangladesh 7
PK - Pakistan 7
UA - Ucraina 7
ES - Italia 6
IQ - Iraq 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
IR - Iran 5
LT - Lituania 5
MG - Madagascar 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CL - Cile 3
CY - Cipro 3
GR - Grecia 3
HU - Ungheria 3
JO - Giordania 3
PE - Perù 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
GT - Guatemala 2
IE - Irlanda 2
JM - Giamaica 2
NP - Nepal 2
SA - Arabia Saudita 2
SV - El Salvador 2
UY - Uruguay 2
AO - Angola 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
HN - Honduras 1
ID - Indonesia 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TN - Tunisia 1
ZM - Zambia 1
Totale 4.007
Salva come PNG Salva come JPEG
Città #
Dallas 386
Ashburn 245
Hong Kong 184
Singapore 175
Santa Clara 139
Chandler 126
Milan 99
Shanghai 77
Vienna 75
Munich 71
New York 70
Beijing 68
Los Angeles 57
Fairfield 47
Pisa 47
Abidjan 43
Sofia 38
Hefei 34
Boardman 31
Seattle 30
Rome 29
Wilmington 27
Cambridge 23
Woodbridge 23
Dakar 22
Florence 22
Houston 22
Princeton 22
Frankfurt am Main 21
Seoul 21
Redondo Beach 20
Lawrence 19
Turku 18
Helsinki 17
Tokyo 17
São Paulo 15
Buffalo 14
London 12
Belo Horizonte 11
Casablanca 11
Cascina 11
Fuzhou 11
Lucca 11
Dong Ket 10
Istanbul 10
Medford 10
Serra 10
Boulder 9
Ann Arbor 8
Denver 8
Montreal 8
San Diego 8
Warsaw 8
Brooklyn 7
Düsseldorf 7
Livorno 7
Mexico City 7
Ogden 7
Quanzhou 7
Bologna 6
Brasília 6
Nuremberg 6
Ottawa 6
Poplar 6
Toronto 6
Vicopisano 6
Antananarivo 5
Bremen 5
Johannesburg 5
Nanjing 5
Rio de Janeiro 5
Samsun 5
Tashkent 5
Vancouver 5
Washington 5
Xiamen 5
Zhengzhou 5
Atlanta 4
Baghdad 4
Baku 4
Brno 4
Chengdu 4
Chicago 4
Dearborn 4
Guangzhou 4
Mumbai 4
Amman 3
Atakum 3
Athens 3
Bari 3
Budapest 3
Campinas 3
Council Bluffs 3
Des Moines 3
Fortaleza 3
Guayaquil 3
Hanoi 3
Ho Chi Minh City 3
Jiaxing 3
Jinan 3
Totale 2.767
Salva come PNG Salva come JPEG
Nome #
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 218
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 210
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 166
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 160
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 151
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 150
The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC) 141
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 130
Recombinant Human Thyrotropin Stimulation Thyroglobulin (rhTSH-Tg) test can identify false serum tg due to heterophilic antibodies in differentiated thyroid cancer (DTC) patients 129
Thyroid cancers: From surgery to current and future systemic therapies through their molecular identities 127
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 126
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 124
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 124
Radioiodine remnant ablation (RRA) Impact on the dynamic risk of restratification in the short-term follow-up of patients with differentiated thyroid cancer (DTC). 117
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia 117
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 116
Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC) 108
Effect of Pregnancy and Menopause on Micropapillary Thyroid Carcinomas During Active Surveillance 102
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 101
Management and follow-up of differentiated thyroid cancer not submitted to radioiodine treatment: a systematic review 97
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 97
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 94
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 93
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib 92
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature 86
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 86
NF1 Gene Inactivation Acts as Tumor Driver in RET/RAS Negative Medullary Thyroid Carcinomas 84
Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer 81
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 80
Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A) 80
Ultrasound features and risk stratification system in NIFT-P and other follicular-patterned thyroid tumors 67
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 66
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine 66
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review 65
Insights into Ultrasound Features and Risk Stratification Systems in Pediatric Patients with Thyroid Nodules 60
Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib 58
Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients 55
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib 44
Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid Cancer 36
Totale 4.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.373
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 8 21 9 7 8 11 23 22
2021/2022167 1 4 5 2 31 28 5 8 9 7 13 54
2022/2023497 32 56 51 36 54 54 20 44 109 5 29 7
2023/2024468 42 56 70 39 62 76 21 7 13 9 30 43
2024/20251.407 26 43 28 82 148 126 129 65 135 161 160 304
2025/20261.110 167 346 274 233 90 0 0 0 0 0 0 0
Totale 4.104